Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for Topical Treatment of Atopic Dermatitis.

MLA

Hiyama, Hidetaka, et al. “Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for Topical Treatment of Atopic Dermatitis.” The Journal of Pharmacology and Experimental Therapeutics, vol. 386, no. 1, July 2023, pp. 45–55. EBSCOhost, https://doi.org/10.1124/jpet.123.001609.

APA

Hiyama, H., Arichika, N., Okada, M., Koyama, N., Tahara, T., & Haruta, J. (2023). Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for Topical Treatment of Atopic Dermatitis. The Journal of Pharmacology and Experimental Therapeutics, 386(1), 45–55. https://doi.org/10.1124/jpet.123.001609

Chicago

Hiyama, Hidetaka, Naoya Arichika, Minoru Okada, Noriyuki Koyama, Tomonori Tahara, and Junpei Haruta. 2023. “Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for Topical Treatment of Atopic Dermatitis.” The Journal of Pharmacology and Experimental Therapeutics 386 (1): 45–55. doi:10.1124/jpet.123.001609.